Clinical trial
A Randomized, Open-Label Study Comparing the Efficacy and Safety of Lidocaine Patch 5% With Celecoxib 200 mg in Patients With Chronic Axial Low Back Pain
NCT00904397 is registered in ClinicalTrials.gov with Endo USA Inc., a Keenova Therapeutics Company as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- A Randomized, Open-Label Study Comparing the Efficacy and Safety of Lidocaine Patch 5% With Celecoxib 200 mg in Patients With Chronic Axial Low Back Pain
- Lead sponsor
- Endo USA Inc., a Keenova Therapeutics Company
- Phase
- Phase 4
- Overall status
- Terminated
- Start date
- July 31, 2004
- Completion date
- Not reported
- Enrollment
- 98 (actual)
- Sites
- 21
Conditions
As the registry lists them; a condition with its own page is linked.
chronic low back pain